Compare HBIO & SNAL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HBIO | SNAL |
|---|---|---|
| Founded | 1901 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Laboratory Analytical Instruments | Computer Software: Prepackaged Software |
| Sector | Industrials | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 26.5M | 26.6M |
| IPO Year | 2000 | 2022 |
| Metric | HBIO | SNAL |
|---|---|---|
| Price | $6.11 | $5.19 |
| Analyst Decision | Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $18.00 | N/A |
| AVG Volume (30 Days) | 12.7K | ★ 680.8K |
| Earning Date | 05-12-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 120.00 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $116,176,000.00 | $81,225,622.00 |
| Revenue This Year | $4.77 | $15.53 |
| Revenue Next Year | $8.55 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.38 | $0.34 |
| 52 Week High | $7.50 | $5.92 |
| Indicator | HBIO | SNAL |
|---|---|---|
| Relative Strength Index (RSI) | 46.83 | 84.21 |
| Support Level | $5.91 | $0.65 |
| Resistance Level | $6.70 | N/A |
| Average True Range (ATR) | 0.28 | 0.50 |
| MACD | -0.03 | 0.36 |
| Stochastic Oscillator | 9.76 | 89.42 |
Harvard Bioscience Inc is a developer, manufacturer, and seller of technologies, products, and services that enable advances in life science applications, including research, drug and therapy discovery, bioproduction, and preclinical testing. The company organizes its product line into two product families: Cellular and Molecular Technologies (CMT) and Preclinical. The CMT product family supports molecular, cellular, organ, and organoid research, as well as bioproduction and in vitro testing, while the Preclinical product family provides products for preclinical research and testing, including data collection and analysis for safety and regulatory compliance. Its geographical segments include the Americas, Europe, Middle East and Africa, and Asia.
Snail Inc is an independent developer and publisher of interactive digital entertainment for consumers around the world, with a portfolio of premium games designed for use on a variety of platforms, including consoles, PC's, and mobile devices. The geographic presence of the company is in the United States and the International market, where the majority of its revenue comes from the United States. The Company has one operating and reportable segment. The company operates in the USA, the UK and Other Countries.